For corals that establish symbioses with dinoflagellate Symbiodinium spp. at the larval stage or later through horizontal transmission, the ecological significance of the early uptake of algal symbionts remains unknown. It has been hypothesized that early uptake of symbionts is an advantage for long-distance dispersal. Here, we tested the hypothesis that early acquisition of symbionts enhances post-settlement survival. We used a cultured strain of clade A Symbiodinium that was isolated from wild Acropora spat as the algal symbiont. Symbiotic and aposymbiotic Acropora larvae were prepared in the laboratory and settled on experimental plates in the field. The survival of settlers was monitored for 15 mo. Our results showed that more larval-stage settlers harbouring symbionts survived than those without, even when there was no difference in the initial density of settled larvae. We analysed the Symbiodinium clades harboured by the corals at 1 mo after settlement, and found that clade A was less abundant in the corals that grew from aposymbiotic larvae than in those that developed from symbiotic larvae. There was also a marked difference in coral survival between aposymbiotic and symbiotic larvae over this period. The higher survival rate of 'early uptake' corals was more pronounced on shaded plates. These results suggest that the early uptake of specific symbionts enhances post-settlement survival in dark places such as reef crevices, which are sites commonly settled by coral larvae.

Poly­(vinylcarbazole) (PVCz) dispersed the typical fullerene derivative, PCBM, well in its solution, which was then coated onto a mesoporous titanium oxide (TiO2) layer. PVCz served as a scaffold to fix PCBM homogeneously and to prevent its elution out upon the following perovskite layer formation. A series of perovskite cells were fabricated upon the PVCz/PCBM-modified TiO2 layer. Many of the cells were characterized by a photovoltaic conversion efficiency of >20%, and the top cells had an efficiency of 21.1% (with an average of 21.0%). Fluorescence decay from the perovskite layer of the cell was unchanged with the PVCz/PCBM modification, suggesting an efficient charge transport to the electron-transporting layers. On the other hand, the PVCz/PCBM modification or passivation significantly reduced electroluminescence intensity under an inverse bias application, supporting an efficient suppression of carrier recombination at the TiO2 and perovskite interface.

It is important to improve the magnitude of dose variation that is caused by the interplay effect. The aim of this study was to investigate the impact of the number of breaths (NBs) to the dose variation for VMAT‐SBRT to lung cancer. Data on respiratory motion and multileaf collimator (MLC) sequence were collected from the cases of 30 patients who underwent radiotherapy with VMAT‐SBRT for lung cancer. The NBs in the total irradiation time with VMAT and the maximum craniocaudal amplitude of the target were calculated. The MLC sequence complexity was evaluated using the modulation complexity score for VMAT (MCSv). Static and dynamic measurements were performed using a cylindrical respiratory motion phantom and a micro ionization chamber. The 1 standard deviation which were obtained from 10 dynamic measurements for each patient were defined as dose variation caused by the interplay effect. The dose distributions were also verified with radiochromic film to detect undesired hot and cold dose spot. Dose measurements were also performed with different NBs in the same plan for 16 patients in 30 patients. The correlations between dose variations and parameters assessed for each treatment plan including NBs, MCSv, the MCSv/amplitude quotient (TMMCSv), and the MCSv/amplitude quotient × NBs product (IVS) were evaluated. Dose variation was decreased with increasing NBs, and NBs of >40 times maintained the dose variation within 3% in 15 cases. The correlation between dose variation and IVS which were considered NBs was shown stronger (R 2 = 0.43, P < 0.05) than TMMCSv (R 2 = 0.32, P < 0.05). The NBs is an important factor to reduce the dose variation. The patient who breathes >40 times during irradiation of two partial arcs VMAT (i.e., NBs = 16 breaths per minute) may be suitable for VMAT‐SBRT for lung cancer.

The objectives of this study were to evaluate dosimetric quality and acute toxicity of volumetric-modulated arc therapy (VMAT) and daily image guidance in high-risk prostate cancer patients. A total of 100 consecutive high-risk prostate cancer patients treated with definitive VMAT with prophylactic whole-pelvic radiotherapy (WPRT) were enrolled. All patients were treated with a double-arc VMAT plan delivering 52 Gy to the prostate planning target volume (PTV), while simultaneously delivering 46.8 Gy to the pelvic nodal PTV in 26 fractions, followed by a single-arc VMAT plan delivering 26 Gy to the prostate PTV in 13 fractions. Image-guided RT was performed with daily cone-beam computed tomography. Dose–volume parameters for the PTV and the organs at risk (OARs), total number of monitor units (MUs) and treatment time were evaluated. Acute toxicity was assessed using the Common Terminology Criteria for Adverse Events, version 4.0. All dosimetric parameters met the present plan acceptance criteria. Mean MU and treatment time were 471 and 146 s for double-arc VMAT, respectively, and were 520 and 76 s for single-arc VMAT, respectively. No Grade 3 or higher acute toxicity was reported. Acute Grade 2 proctitis, diarrhea, and genitourinary toxicity occurred in 12 patients (12%), 6 patients (6%) and 13 patients (13%), respectively. The present study demonstrated that VMAT for WPRT in prostate cancer results in favorable PTV coverage and OAR sparing with short treatment time and an acceptable rate of acute toxicity. These findings support the use of VMAT for delivering WPRT to high-risk prostate cancer patients.

No abstract